Business
Currency:HKD
2023/FY
Stock NameRevenueRatio
药物和医疗科技业务470.69M88.46%
Chinese medicine business48.37M9.09%
医疗和保健服务13.04M2.45%
Product
Currency:HKD
2018/FY
Stock NameRevenueRatio
Brain protein hydrolysate for injection158.27M43.77%
Other products81.37M22.50%
托恩(布洛芬混悬液及滴剂)65.29M18.06%
托平(缬沙坦胶囊)56.63M15.66%
Region
Currency:HKD
2023/FY
Stock NameRevenueRatio
Chinese mainland524.13M98.50%
Hong Kong6.47M1.22%
Australia1.49M0.28%